ImmunoPrecise Antibodies Price to Book Ratio 2022-2025 | IPA

Historical price to book ratio values for ImmunoPrecise Antibodies (IPA) over the last 10 years. The current price to book ratio for ImmunoPrecise Antibodies as of May 09, 2025 is 0.79.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

ImmunoPrecise Antibodies Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-05-09 0.45 1.16
2025-01-31 0.47 $0.39 1.20
2024-10-31 0.48 $0.79 0.60
2024-07-31 0.79 $0.88 0.90
2024-04-30 1.28 $0.93 1.37
2024-01-31 1.81 $1.40 1.29
2023-10-31 2.30 $1.53 1.51
2023-07-31 2.52 $1.61 1.56
2023-04-30 2.57 $1.74 1.48
2023-01-31 4.40 $1.82 2.42
2022-10-31 4.97 $1.86 2.67
2022-07-31 4.23 $2.07 2.04
2022-04-30 5.56 $2.45 2.27
2022-01-31 6.18 $1.93 3.20
2021-10-31 6.57 $2.09 3.14
2021-07-31 6.58 $2.34 2.81
2021-04-30 9.76 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.021B $0.018B
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.567B 53.27
Hims & Hers Health (HIMS) United States $11.630B 120.84
Tempus AI (TEM) United States $10.569B 0.00
Inspire Medical Systems (INSP) United States $4.461B 69.70
IRhythm Technologies (IRTC) United States $4.396B 0.00
Privia Health (PRVA) United States $3.035B 208.50
Enovis (ENOV) United States $1.887B 10.53
Clover Health Investments (CLOV) United States $1.793B 0.00
Schrodinger (SDGR) United States $1.746B 0.00
Phreesia (PHR) United States $1.506B 0.00
Azenta (AZTA) United States $1.223B 56.96
Omnicell (OMCL) United States $1.208B 21.31
10x Genomics (TXG) United States $1.073B 0.00
Fulgent Genetics (FLGT) United States $0.600B 0.00
Butterfly Network (BFLY) United States $0.551B 0.00
Talkspace (TALK) United States $0.509B 151.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.371B 827.00
Claritev (CTEV) United States $0.351B 0.00
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.136B 0.00
American Well (AMWL) United States $0.107B 0.00
Retrieve Medical Holdings (RMHI) United States $0.089B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
CareCloud (CCLD) United States $0.081B 3.07
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.060B 0.00
Outset Medical (OM) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00